BioAge Labs, Inc.

NASDAQ:BIOA

Biotechnology

Healthcare
$4.77 +2.35%

+$0.47 today

Market cap
$179.59M
Beta
0.95
P/E (TTM)
-9.7
EPS (TTM)
-$2.12
52W Low $4.07High $24.00

Volume 0.64M

Average 0.46M

BIOA Total Non-current Assets

All assets not expected to be converted to cash within one year.

BioAge Labs, Inc.NASDAQ: BIOA

Total Non-current Assets · Q1 FY2026 · quarter ended Mar 2026

Total non-current assets falls 69.6% from a year ago

Total non-current assets stood at $5.79M at the end of Q1 FY2026, down 69.6% from a year earlier and down 28.4% from the prior quarter. Over 3 fiscal years it compounded at +172.8% a year.

Context

  • Total non-current assets amounted to 1.5% of total assets at the end of Q1 FY2026, down 4.1 pp from a year earlier.
  • Total non-current assets increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether total non-current assets keeps falling in the next quarterly balance sheet after a -69.6% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterMar 2026
$5.79M-28.4% QoQ
Last fiscal yearDec 2025
$8.1M+615.8% YoY
Year agoMar 2025
$19.03M-69.6% since
Total Non-current Assets past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-69.6%——
1 year+615.8%——
3-year CAGR+172.8%——
5-year CAGR——
10-year CAGR——

Total Non-current Assets history

USD · from the balance sheet

Latest · FY2025
8.1M USD
Year-over-year change
+615.8%
3-year CAGR
+172.8%

Total Non-current Assets vs competitors

How BIOA compares with its peers on the latest reported figures

  • Peers report in different currencies, so total non-current assets is compared through growth and share of total assets rather than absolute size.
  • Its year-over-year change of -69.6% is the lowest of 9, against a peer median of -40.7%.
  • Total non-current assets amounts to 1.5% of total assets for BIOA, versus a peer median of 33.9%.
BIOA Competitors
Total Non-current Assets for BIOA and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
CGCCanopy Growth CorporationMar 2026CA$589.27M CAD-5.4%-15.5%52.7%
ACBAurora Cannabis Inc.Mar 2026CA$204.16M CAD-45.1%-23.0%33.9%
LFCRLifecore Biomedical, Inc.Dec 2025$149.89M USD——64.6%
ALLOAllogene Therapeutics, Inc.Mar 2026$122.67M USD-43.3%-18.6%31.0%
TKNOAlpha Teknova, Inc.Mar 2026$66.98M USD-9.8%-8.8%67.9%
HUMAHumacyte, Inc.Mar 2026$46.96M USD-47.1%-1.0%42.5%
CABACabaletta Bio, Inc.Mar 2026$25.83M USD-15.4%+47.7%17.4%
EDITEditas Medicine, Inc.Mar 2026$21.27M USD-45.2%-47.6%14.2%
BIOABioAge Labs, Inc.Mar 2026$5.79M USD-69.6%+172.8%1.5%
AVIRAtea Pharmaceuticals, Inc.Mar 2026$3.88M USD-38.0%-9.9%1.5%
Peer median (excluding BIOA) —-40.7%-12.7%33.9%

Competitors are the stored peer set for BIOA. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents27.64M21.64M354.35M188.89M
Short-term Investments00092.21M
Net Receivables000769K
Inventory0000
Other Current Assets386K3.66M2.75M4.93M
Total Current Assets28.03M25.31M357.1M286.79M
Property, Plant & Equipment (Net)374K518K791K3.75M
Goodwill0000
Intangible Assets0000
Long-term Investments0100K100K100K
Tax Assets0000
Other Non-current Assets25K0240K4.25M
Total Non-current Assets399K618K1.13M8.1M
Total Assets28.43M25.92M358.23M294.89M
Account Payables2.26M1.87M2M2.67M
Short-term Debt167K44.86M6M2.65M
Tax Payables0000
Deferred Revenue03.31M7.83M5.75M
Other Current Liabilities24K1.39M417K525K
Total Current Liabilities5.86M58.17M27.78M20.14M
Long-term Debt2.25M8.2M2.5M2.33M
Deferred Tax Liabilities0000
Deferred Revenue (Non-current)004.67M0
Other Non-current Liabilities132.88M132.95M156K370K
Total Non-current Liabilities135.13M141.15M7.33M2.7M
Total Liabilities140.99M199.32M35.11M22.84M
Common Stock0000
Retained Earnings(117.85M)(181.7M)(252.81M)(333.42M)
Accumulated OCI167K164K245K278K
Other Stockholders Equity0000
Minority Interest0000
Total Equity(112.56M)(173.4M)323.13M272.05M
Total Debt2.47M53.25M8.7M5.56M
Net Debt(25.18M)31.61M(345.65M)(183.33M)

BioAge Labs, Inc.

NASDAQ:BIOA

Intrinsic Alpha fair value

Locked

Current Price

$4.77

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.